Repligen (RGEN) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.01% |
| Dec 31, 2025 | -8.57% |
| Sep 30, 2025 | -0.75% |
| Jun 30, 2025 | -2.82% |
| Mar 31, 2025 | -11.09% |
| Dec 31, 2024 | -60.69% |
| Sep 30, 2024 | -18.47% |
| Jun 30, 2024 | -10.07% |
| Mar 31, 2024 | -18.80% |
| Dec 31, 2023 | -34.08% |
| Sep 30, 2023 | 24.57% |
| Jun 30, 2023 | 42.29% |
| Mar 31, 2023 | 27.54% |
| Dec 31, 2022 | 25.78% |
| Sep 30, 2022 | 45.20% |
| Jun 30, 2022 | 29.67% |
| Mar 31, 2022 | 55.18% |
| Dec 31, 2021 | 27.23% |
| Sep 30, 2021 | 80.83% |
| Jun 30, 2021 | 42.22% |
| Mar 31, 2021 | 59.74% |
| Dec 31, 2020 | 104.77% |
| Sep 30, 2020 | 27.54% |
| Jun 30, 2020 | 22.22% |
| Mar 31, 2020 | 14.87% |
| Dec 31, 2019 | 55.18% |
| Sep 30, 2019 | -5.59% |
| Jun 30, 2019 | 13.56% |
| Mar 31, 2019 | 5.51% |
| Dec 31, 2018 | 3.71% |
| Sep 30, 2018 | -11.09% |
| Jun 30, 2018 | -15.59% |
| Mar 31, 2018 | 2.71% |
| Dec 31, 2017 | -2.09% |
| Sep 30, 2017 | 12.89% |
| Jun 30, 2017 | 36.85% |
| Sep 30, 2016 | 8.45% |
| Jun 30, 2016 | 129.47% |
| Mar 31, 2016 | 23.16% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 31.95% |
| Jun 30, 2015 | 29.67% |